| ［1］ |
中国中西医结合学会皮肤性病专业委员会色素病学组. 白癜风诊疗共识（2014版）［J］. 中华皮肤科杂志, 2014, 47（1）: 69⁃71. DOI: 10.3760/cma.j.issn.0412⁃4030.2014.01.024.
|
| ［2］ |
Ezzedine K, Lim HW, Suzuki T, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference［J］. Pigment Cell Melanoma Res, 2012, 25（3）: E1⁃13. DOI: 10.1111/j.1755⁃148X.2012.00997.x.
|
| ［3］ |
Hann SK, Lee HJ. Segmental vitiligo: clinical findings in 208 patients［J］. J Am Acad Dermatol, 1996, 35（5 Pt 1）: 671⁃674. DOI: 10.1016/S0190⁃9622（96）90718⁃5.
|
| ［4］ |
Glassman SJ. Vitiligo, reactive oxygen species and T⁃cells［J］. Clin Sci （Lond）, 2011, 120（3）: 99⁃120. DOI: 10.1042/CS20090603.
|
| ［5］ |
van Geel N, Speeckaert R, Taieb A, et al. Koebner′s phenomenon in vitiligo: European position paper［J］. Pigment Cell Melanoma Res, 2011, 24（3）: 564⁃573. DOI: 10.1111/j.1755⁃148X.2011. 00838.x.
|
| ［6］ |
Diallo A, Boniface K, Jouary T, et al. Development and validation of the K⁃VSCOR for scoring Koebner′s phenomenon in vitiligo/non⁃segmental vitiligo［J］. Pigment Cell Melanoma Res, 2013, 26（3）: 402⁃407. DOI: 10.1111/pcmr.12065.
|
| ［7］ |
van Geel N, Speeckaert R, De Wolf J, et al. Clinical significance of Koebner phenomenon in vitiligo［J］. Br J Dermatol, 2012, 167（5）: 1017⁃1024. DOI: 10.1111/j.1365⁃2133.2012.11158.x.
|
| ［8］ |
Le PIC, van den Wijngaard RM, Westerhof W, et al. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance［J］. Am J Pathol, 1996, 148（4）: 1219⁃1228.
|
| ［9］ |
Hann SK, Kim YS, Yoo JH, et al. Clinical and histopathologic characteristics of trichrome vitiligo［J］. J Am Acad Dermatol, 2000, 42（4）: 589⁃596. DOI: 10.1016/S0190⁃9622（00）90170⁃1.
|
| ［10］ |
Sosa JJ, Currimbhoy SD, Ukoha U, et al. Confetti⁃like depigmentation: A potential sign of rapidly progressing vitiligo［J］. J Am Acad Dermatol, 2015, 73（2）: 272⁃275. DOI: 10.1016/j.jaad.2015.05.014.
|
| ［11］ |
黄骏, 章玲玲, 洪为松，等. 自体培养黑素细胞移植治疗白癜风供皮区出现同形反应者的疗效及相关因素分析［J］. 中华皮肤科杂志, 2017, 50（3）: 186⁃189. DOI: 10.3760/cma.j.issn.0412⁃4030.2017.03.008.
|
| ［12］ |
Rashighi M, Harris JE. Sampling Serum in Patients With Vitiligo to Measure Disease Activity in the Skin［J］. JAMA Dermatol, 2016, 152（11）: 1187⁃1188. DOI: 10.1001/jamadermatol.2016. 2501.
|
| ［13］ |
Rashighi M, Harris JE. Serum chemokines herald disease activity and treatment response in vitiligo patients［J］. Br J Dermatol, 2016, 174（6）: 1190⁃1191. DOI: 10.1111/bjd.14671.
|
| ［14］ |
Strassner JP, Rashighi M, Ahmed RM, et al. Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity［J］. J Am Acad Dermatol, 2017, 76（5）: 847⁃855.e5. DOI: 10.1016/j.jaad.2016.12.021.
|
| ［15］ |
李阳, 祝逸平, 许爱娥. 387例节段型白癜风患者的临床分析［J］. 中华皮肤科杂志, 2013, 46（10）: 749⁃750. DOI: 10.3760/cma.j.issn.0412⁃4030.2013.10.019.
|
| ［16］ |
Taieb A, Alomar A, Böhm M, et al. Guidelines for the management of vitiligo: the European Dermatology Forum consensus［J］. Br J Dermatol, 2013, 168（1）: 5⁃19. DOI: 10.1111/j.1365⁃2133.2012. 11197.x.
|
| ［17］ |
Birlea SA, Goldstein NB, Norris DA. Repigmentation through Melanocyte Regeneration in Vitiligo［J］. Dermatol Clin, 2017, 35（2）: 205⁃218. DOI: 10.1016/j.det.2016.11.015.
|
| ［18］ |
林洁, 樊奇敏, 许爱娥. 窄谱中波紫外线治疗白癜风平台期相关研究［J］. 临床皮肤科杂志, 2016, 45（06）: 465⁃468.
|
| ［19］ |
Gan EY, Kong YL, Tan WD, et al. Twelve⁃month and sixty⁃month outcomes of noncultured cellular grafting for vitiligo［J］. J Am Acad Dermatol, 2016, 75（3）: 564⁃571. DOI: 10.1016/j.jaad.2016. 04.007.
|
| ［20］ |
van Geel N , Wallaeys E , Goh BK， et al. Long⁃term results of noncultured epidermal cellular grafting in vitiligo, halo naevi, piebaldism and naevus depigmentosus［J］. Br J Dermatol, 2010, 163（6）: 1186⁃1193. DOI: 10.1111/j.1365⁃2133.2010.10014.x.
|
| ［21］ |
Zhang DM, Hong WS, Fu LF, et al. A randomized controlled study of the effects of different modalities of narrow⁃band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo［J］. Dermatol Surg, 2014, 40（4）: 420⁃426. DOI: 10.1111/dsu.12444.
|
